A detailed history of Bull Street Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Bull Street Advisors, LLC holds 14,770 shares of NVO stock, worth $1.31 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
14,770
Previous 15,010 1.6%
Holding current value
$1.31 Million
Previous $2.14 Million 17.92%
% of portfolio
0.82%
Previous 1.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$119.07 - $145.42 $28,576 - $34,900
-240 Reduced 1.6%
14,770 $1.76 Million
Q2 2024

Jul 26, 2024

SELL
$122.71 - $146.91 $26,996 - $32,320
-220 Reduced 1.44%
15,010 $2.14 Million
Q1 2024

Apr 29, 2024

SELL
$102.11 - $135.92 $35,738 - $47,571
-350 Reduced 2.25%
15,230 $1.96 Million
Q4 2023

Jan 29, 2024

SELL
$87.78 - $105.45 $13,167 - $15,817
-150 Reduced 0.95%
15,580 $1.61 Million
Q3 2023

Oct 30, 2023

BUY
$90.94 - $199.54 $710,696 - $1.56 Million
7,815 Added 98.74%
15,730 $1.43 Million
Q2 2023

Jul 28, 2023

SELL
$155.98 - $172.65 $142,721 - $157,974
-915 Reduced 10.36%
7,915 $1.28 Million
Q1 2023

Apr 26, 2023

SELL
$132.34 - $159.14 $5,293 - $6,365
-40 Reduced 0.45%
8,830 $1.41 Million
Q4 2021

Feb 03, 2022

SELL
$95.88 - $117.08 $9,588 - $11,708
-100 Reduced 1.11%
8,870 $993,000
Q3 2021

Nov 05, 2021

SELL
$84.42 - $106.62 $8,442 - $10,662
-100 Reduced 1.1%
8,970 $861,000
Q2 2020

Aug 06, 2020

SELL
$58.54 - $67.94 $7,317 - $8,492
-125 Reduced 1.36%
9,070 $594,000
Q1 2020

May 01, 2020

SELL
$49.46 - $64.78 $6,924 - $9,069
-140 Reduced 1.5%
9,195 $554,000
Q4 2019

Jan 29, 2020

SELL
$49.86 - $58.26 $8,725 - $10,195
-175 Reduced 1.84%
9,335 $540,000
Q3 2019

Nov 08, 2019

BUY
$47.54 - $53.43 $452,105 - $508,119
9,510 New
9,510 $492,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $200B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bull Street Advisors, LLC Portfolio

Follow Bull Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bull Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bull Street Advisors, LLC with notifications on news.